Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edison T Liu

Showing results (141-150 of 198) with videos related to

Pageof 20
Sort By:
Oncogene|February 4, 2005
Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumorsHyun Ju Kang, Suk Woo Nam, Hyunki Kim, et al.
Molecular Systems Biology|November 20, 2025
Molecular Systems Biology at 20: reflecting on the past, envisioning the futurePoonam Bheda, Jingyi Hou, Ruedi Aebersold, et al.
BMC Medicine|July 4, 2006
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort studyPer Hall, Alexander Ploner, Judith Bjöhle, et al.
Genome Biology|September 12, 2006
Multiplatform genome-wide identification and modeling of functional human estrogen receptor binding sitesVinsensius B Vega, Chin-Yo Lin, Koon Siew Lai, et al.
Breast Cancer Research : BCR|April 13, 2007
Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancerChin-Yo Lin, Anders Ström, Say Li Kong, et al.
BMC Infectious Diseases|September 11, 2004
A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infectionLisa F P Ng, Martin L Hibberd, Eng-Eong Ooi, et al.
Science Translational Medicine|July 20, 2022
Genomic and epigenomic <i>BRCA</i> alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomasFrancesca Menghi, Kalyan Banda, Pooja Kumar, et al.
Neoplasia (New York, N.Y.)|December 21, 2010
Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinomaNagarajan Kannan, Jian Kang, Xiangjun Kong, et al.
Communications Medicine|May 23, 2022
Reduced subgenomic RNA expression is a molecular indicator of asymptomatic SARS-CoV-2 infectionChee Hong Wong, Chew Yee Ngan, Rachel L Goldfeder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2026
HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic ImplicationsKalyan Banda, Helen R Davies, Yogesh Kumar, et al.
Pageof 20

Showing results (141-150 of 198) with videos related to

Sort By:
Pageof 20
Oncogene|February 4, 2005
Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumorsHyun Ju Kang, Suk Woo Nam, Hyunki Kim, et al.
Molecular Systems Biology|November 20, 2025
Molecular Systems Biology at 20: reflecting on the past, envisioning the futurePoonam Bheda, Jingyi Hou, Ruedi Aebersold, et al.
BMC Medicine|July 4, 2006
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort studyPer Hall, Alexander Ploner, Judith Bjöhle, et al.
Genome Biology|September 12, 2006
Multiplatform genome-wide identification and modeling of functional human estrogen receptor binding sitesVinsensius B Vega, Chin-Yo Lin, Koon Siew Lai, et al.
Breast Cancer Research : BCR|April 13, 2007
Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancerChin-Yo Lin, Anders Ström, Say Li Kong, et al.
BMC Infectious Diseases|September 11, 2004
A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infectionLisa F P Ng, Martin L Hibberd, Eng-Eong Ooi, et al.
Science Translational Medicine|July 20, 2022
Genomic and epigenomic <i>BRCA</i> alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomasFrancesca Menghi, Kalyan Banda, Pooja Kumar, et al.
Neoplasia (New York, N.Y.)|December 21, 2010
Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinomaNagarajan Kannan, Jian Kang, Xiangjun Kong, et al.
Communications Medicine|May 23, 2022
Reduced subgenomic RNA expression is a molecular indicator of asymptomatic SARS-CoV-2 infectionChee Hong Wong, Chew Yee Ngan, Rachel L Goldfeder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2026
HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic ImplicationsKalyan Banda, Helen R Davies, Yogesh Kumar, et al.
Pageof 20